Positron Corporation Announces Sale of NeuSight PET-CT Scanner
Positron Corporation (OTC: POSC), a prominent company in the field of molecular imaging medical devices, is excited to announce the sale of its NeuSight PET-CT 64 slice scanner to a well-respected leader in preventive, invasive, and interventional cardiovascular services.
Innovative Features of NeuSight PET-CT Scanner
The NeuSight PET-CT scanner is designed to transform cardiac PET imaging, delivering exceptional value and equipping practices with cutting-edge technology at an unbeatable price. With over 500 installations globally, this high-performing scanner prioritizes patient comfort, featuring a spacious 72cm gantry. It also utilizes high-sensitivity acquisition technology that ensures safety by minimizing radiation exposure for both patients and technicians. Notably, the NeuSight PET-CT scanner has the smallest footprint and lightest weight of any 64 slice PET-CT system currently available in the industry.
Efficiency in Clinical Applications
This innovative and cost-effective PET-CT system is particularly well-suited for clinical studies in both cardiology and oncology. It offers superior data acquisition capabilities, along with advanced identification technology that enhances scanning speed and accuracy. The system enables both anatomic and functional imaging with its qualified designs and advanced technology, making it versatile for various molecular imaging functions related to heart, tumor, and brain studies.
Statements from Leadership
Adel Abdullah, President of Positron, shared his excitement, stating, “We are thrilled to have our first NeuSight PET-CT with such a distinguished cardiovascular physician and practice, committed to providing expert cardiac care. We look forward to supporting their needs as they grow their practice in the future.”
Mr. Abdullah added, “Since the launch of our NeuSight PET-CT, we have been delighted by the interest from numerous nuclear cardiologists in our PET-CT technology and its unmatched price point in the imaging market. The NeuSight PET-CT is the ideal solution for advanced nuclear cardiac studies, and we are eager to continue delivering this unique blend of technology, services, and value to practices and hospitals for years to come.”
About Positron Corporation
Positron Corporation is a medical technology firm that co-develops, manufactures, and sells cutting-edge PET and PET-CT imaging systems, along with clinical services, to nuclear medicine healthcare providers throughout North America. Focusing on cardiac Positron Emission Tomography (PET) imaging, Positron’s innovative technologies and clinical services empower healthcare providers to accurately diagnose coronary artery disease, ultimately leading to better patient outcomes while ensuring cost-effective practices.
Future Developments and Market Position
Positron's Attrius PET and NeuSight PET-CT imaging systems provide significant advantages that promote the widespread adoption of cardiac PET and contribute to the growth of the nuclear imaging market. The company plans to enhance its offerings with the upcoming introduction of a state-of-the-art PET-CT 4D molecular imaging device called the Affinity PET-CT 4D 64-Slice. This new device will enable nuclear cardiologists to fully leverage the capabilities of molecular imaging and nuclear medicine. Additionally, Positron’s PET-CT systems position the company to address the increasing demands of the oncology imaging segment within nuclear medicine.
Commitment to Advancing Technology
Positron is committed to expanding the cardiac and oncology PET modalities by providing the best technology and value to imaging specialists. The company is focused on advancing its technology through collaboration with its co-developer, supplier, and R&D partner, Shenyang Intelligent Nuclear Technology Co., a subsidiary of Neusoft Medical Systems.
Frequently Asked Questions
What is the NeuSight PET-CT scanner?
The NeuSight PET-CT scanner is a cutting-edge imaging device designed for cardiac and oncology studies, recognized for its compact size and advanced data acquisition technology.
Who is Positron Corporation?
Positron Corporation is a medical technology company that specializes in the development and sale of PET and PET-CT imaging systems for nuclear medicine healthcare providers.
What advantages does the NeuSight PET-CT offer?
The NeuSight PET-CT provides enhanced patient comfort, minimal radiation exposure, and superior scanning speed and accuracy, making it suitable for a range of clinical applications.
How many installations has the NeuSight scanner achieved?
The NeuSight PET-CT scanner has reached over 500 installations worldwide, showcasing its acceptance and performance in the market.
What is Positron's future direction?
Positron aims to advance its technologies and expand its product offerings, including the upcoming Affinity PET-CT 4D 64-Slice device, to meet the growing demands in cardiac and oncology imaging.
